Apoptosis Technology, Inc.
10Patents
0Active
10Granted
26Portfolio score
Filing activity: May 12, 1995 → Jun 18, 2003
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5656725A | Peptides and compositions which modulate apoptosis | Physics | 15 | Expired |
| US5958872A | Active survival domains of IGF-IR and methods of use | Human Necessities | 8 | Expired |
| US6221615A | Peptides and compositions which modulate apoptosis | Physics | 7 | Expired |
| US6605426B1 | Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products | Physics | 4 | Expired |
| US5843659A | Apoptosis gene EI24, compositions, and methods of use | Chemistry; Metallurgy | 4 | Expired |
| US6218511A | Anti-apoptotic genes of human cytomegalovirus (HCMV) and their use | Physics | 1 | Expired |
| US6596473B1 | Active survival domains of IGF-IR and methods of use | Human Necessities | 0 | Expired |
| US6586204B2 | Apoptosis gene EI24, compositions, and methods of use | Chemistry; Metallurgy | 0 | Expired |
| US5863795A | Nucleic acids that encode peptides which modulate apoptosis | Physics | 0 | Expired |
| US6902885B2 | Compounds, methods of screening, and in vitro and in vivo uses involving anti-apoptotic genes and anti-apoptotic gene products | Physics | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.